Address
Email address
https://iconplc.comICON plc | Clinical Research Organisation (CRO) for Drug DevelopmentICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
Name
KCR Baltics OÜ
Registry code
12229831
VAT number
EE101529545
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
02.02.2012 (13)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c.
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing LEINONEN 10391964 | - | Contact person | - | |
| Mike Jagielski
| - | Board member | - | |
| Altius Advisory OÜ 12051066 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 312 917.73 € | 141 294.71 € | 151 855.03 € | 22 |
| 2024 Q3 | 445 898.22 € | 145 329.21 € | 156 044.11 € | 22 |
| 2024 Q2 | 471 010.23 € | 162 722.2 € | 143 824.36 € | 24 |
| 2024 Q1 | 619 408.89 € | 128 693.6 € | 136 429.88 € | 20 |
| 2023 Q4 | 459 209.77 € | 116 941.34 € | 124 804.02 € | 18 |
| 2023 Q3 | 456 421 € | 141 636.78 € | 123 847.95 € | 17 |
| 2023 Q2 | 462 614.71 € | 110 316.74 € | 115 751.32 € | 17 |
| 2023 Q1 | 445 198.95 € | 105 850.68 € | 110 201.98 € | 17 |
| 2022 Q4 | 459 792.59 € | 119 002.72 € | 103 814.07 € | 17 |
| 2022 Q3 | 441 189.83 € | 92 202.59 € | 97 709.86 € | 15 |
| 2022 Q2 | 385 858.36 € | 89 745.08 € | 94 104.78 € | 15 |
| 2022 Q1 | 438 657.2 € | 86 961.09 € | 92 005.83 € | 15 |
| 2021 Q4 | 95 557.57 € | 21 889.41 € | 23 175.06 € | 14 |
| 2021 Q3 | 49 705.2 € | 42 741.6 € | 20 092.71 € | 4 |
| 2021 Q2 | 52 584.6 € | 15 610.56 € | 16 921.53 € | 4 |
| 2021 Q1 | 67 500 € | 14 985.44 € | 16 246.66 € | 4 |
| 2020 Q4 | 70 000 € | 15 384.61 € | 16 653.68 € | 6 |
| 2020 Q3 | 90 000 € | 24 828.03 € | 26 742.25 € | 6 |
| 2020 Q2 | 97 500 € | 34 779.9 € | 28 508.84 € | 7 |
| 2020 Q1 | 140 233.85 € | 31 282.96 € | 33 915.81 € | 8 |
